- Home
- ATHA vs EPOW Comparison
ATHA vs EPOW Comparison
Compare ATHA & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- EPOW
- Stock Information
- Founded
- ATHA 2011
- EPOW 2014
- Country
- ATHA United States
- EPOW China
- Employees
- ATHA N/A
- EPOW N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- EPOW Business Services
- Sector
- ATHA Health Care
- EPOW Consumer Discretionary
- Exchange
- ATHA Nasdaq
- EPOW Nasdaq
- Market Cap
- ATHA 21.0M
- EPOW 22.5M
- IPO Year
- ATHA 2020
- EPOW 2021
- Fundamental
- Price
- ATHA $0.53
- EPOW $0.86
- Analyst Decision
- ATHA Buy
- EPOW
- Analyst Count
- ATHA 4
- EPOW 0
- Target Price
- ATHA $11.25
- EPOW N/A
- AVG Volume (30 Days)
- ATHA 235.4K
- EPOW 19.1K
- Earning Date
- ATHA 02-20-2025
- EPOW 01-01-0001
- Dividend Yield
- ATHA N/A
- EPOW N/A
- EPS Growth
- ATHA N/A
- EPOW N/A
- EPS
- ATHA N/A
- EPOW N/A
- Revenue
- ATHA N/A
- EPOW $46,625,085.00
- Revenue This Year
- ATHA N/A
- EPOW N/A
- Revenue Next Year
- ATHA N/A
- EPOW N/A
- P/E Ratio
- ATHA N/A
- EPOW N/A
- Revenue Growth
- ATHA N/A
- EPOW N/A
- 52 Week Low
- ATHA $0.41
- EPOW $0.53
- 52 Week High
- ATHA $4.30
- EPOW $1.36
- Technical
- Relative Strength Index (RSI)
- ATHA 41.88
- EPOW 47.97
- Support Level
- ATHA $0.52
- EPOW $0.88
- Resistance Level
- ATHA $0.57
- EPOW $1.08
- Average True Range (ATR)
- ATHA 0.04
- EPOW 0.08
- MACD
- ATHA -0.00
- EPOW -0.00
- Stochastic Oscillator
- ATHA 11.82
- EPOW 21.43
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is into the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.